SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

12 Months Ended

Dec. 31, 2014

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

Balance sheets:

	December 31,
(U.S. dollars in thousands)	2013		2014
a.        Other assets:
Institutions	$	356	$	124
State of Israel (see Note 6a)		366		1,229
Restricted deposit		362		416
Prepaid expenses		286		369
Sundry		87		64
	$	1,457	$	2,202

(U.S. dollars in thousands)
b.         Accounts payable and accruals – other:
Payroll and related expenses	$	1,557		1,243
Interest payable		888		914
Provision for vacation		1,572		1,412
Accrued expenses		1,785		5,097
Royalties payable		419		495
Liability in connection with collaboration operation - current portion		5,666		6,215
Property and equipment suppliers		186		120
	$	12,073	$	15,496

Statements of operations:
	Year ended December 31,
	2012		2013		2014
(U.S. dollars in thousands)
c.      Revenues:
Deferred revenues from the license and supply agreement with Pfizer	$	4,563	$	4,563	$	4,563
Milestone payment (see Note 2)		25,000
Revenues from selling products		5,307		5,916		9,088
	$	34,870	$	10,479	$	13,651